Form 4 for CLYM Climb Bio, Inc.
Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-18 · accession 0000950170-25-042777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-03-20 | 2025-03-18 | CLYM | Pimblett Emily | SVP, CAO, Fin | M - OptEx | — | +5,000 | 16.3K | +44% | — |
| DT | 2025-03-20 | 2025-03-20 | CLYM | Pimblett Emily | SVP, CAO, Fin | S - Sale+OE | $1.31 | -1,199 | 15.1K | -7% | -$1,571 |
| DT | 2025-03-20 | 2025-03-18 | CLYM | Pimblett Emily | SVP, CAO, Fin | M - OptEx | $0.00 | -5,000 | 20.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-18 | M | A | 5,000 | — | 16,329 | D | — | — | (F1) Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2025-03-20 | S | D | 1,199 | $1.31 | 15,130 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.31 to $1.325, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| 3 | Derivative | Restricted Stock Units | 2025-03-18 | M | D | 5,000 | $0.00 | 20,000 | D | — · — to — | 5,000 Common Stock | (F4) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F5) The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date. |